Gene drives enable a super-Mendelian inheritance where the chance of passing on the gene to the progeny is 100%, and this super-Mendelian inheritance has been demonstrated for several engineered genes in multiple organisms. Gene-drive mediated trait propagation in the entire ecosystem may find use in the elimination of diseases (e.g., malaria, dengue fever) or invasive species, and reversing the pesticide resistance in plants. We propose to use tools and principles of chemistry to develop controllers that will allow us to understand the strength and limitations of the gene drive technologies. 1

Public Health Relevance

CRISPR-associated nucleases have furnished transformative biomedical technologies, including gene drives that allow one to bypass the normal Mendelian inheritance. We propose to apply tools and principles of chemistry to control and understand the strengths and limits of the gene drive technology. PHS 398/2590 (Rev. 1 06/09) Continuation Format Page

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM132825-01
Application #
9728386
Study Section
Genomics, Computational Biology and Technology Study Section (GCAT)
Program Officer
Fabian, Miles
Project Start
2019-09-01
Project End
2023-07-31
Budget Start
2019-09-01
Budget End
2020-07-31
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115